Detailed Narrative
Financial Performance Overview
PTC India Financial Services Limited reported a strong financial performance in FY26, with Profit After Tax (PAT) rising to INR319 crores from INR217 crores in FY25, marking a 46.9% year-on-year growth. Despite a slight dip in total income to INR518 crores from INR638 crores, the company achieved significant improvements in profitability metrics. The annualized Return on Assets (RoA) improved to 6% from 3.56%, and the annualized Return on Net Worth (RoNW) increased to 10.95% from 8.2%.
Asset Quality Enhancement
The company demonstrated substantial improvement in asset quality during FY26. Gross Stage III assets declined significantly by 73% to INR190 crores from INR711 crores in FY25. Similarly, Net Stage III assets saw an 83% reduction, falling to INR47 crores from INR284 crores. The provision coverage ratio for Stage III assets improved materially to 75% in FY26 from 60% in FY25, underscoring a strengthened balance sheet and prudent risk management approach.
Business Growth and Diversification
FY26 witnessed a sharp acceleration in business activity, with loan sanctions surging over 300% to INR3,448 crores compared to INR825 crores in FY25. Disbursements also grew by 34.8% to INR1,235 crores from INR916 crores in the previous year. The company's focus remains firmly on the infrastructure sector, primarily renewable energy, transmission, distribution, and new segments like data centers and compressed biogas, with 100% of disbursements directed to private corporate borrowers.
Funding and Liquidity Management
The company maintains a strong liquidity position, with INR1,800 crores available on its balance sheet. This enables it to fund current disbursements without immediate new borrowings, as borrowing incurs a cost. Management is actively engaging with lenders to reduce the cost of borrowing, which is currently below 9.5%, and expects further reductions as fresh borrowings are made, leading to a consistent decline in the PFS Base Rate.
Management and Governance Updates
The company addressed the resignation of its MD, Mr. R. Balaji, attributing it to personal reasons and confirming that the process for his replacement is underway, with the current MD remaining until June 30. All Board-level positions are currently filled. CRISIL also removed the company's rating from 'Watch with Developing Implications' and reaffirmed it at CRISIL A (Negative)/A1, indicating improved confidence in the company's governance and financial health.
Dividend Policy and Investor Relations
Despite reporting strong profits for FY26, the company did not declare a dividend, a decision that raised concerns among individual investors. Management stated that the dividend decision would be reviewed in the next quarter, emphasizing that the current focus is on increasing capital appreciation and improving net worth for stakeholders. This approach aims to deliver long-term value to all stakeholders.